Medtronic Launches InFuse Bone Graft To Treat Tibial Fractures
This article was originally published in The Gray Sheet
Executive Summary
Medtronic believes its InFuse bone graft could become the standard of care, in conjunction with intramedullary nails, for acute, open tibial shaft fractures
You may also be interested in...
Approvals Get Medtronic Into Dental And Pediatric Diabetes Markets
Medtronic will soon take its first steps into both the dental market and the pediatric glucose monitor market
Approvals Get Medtronic Into Dental And Pediatric Diabetes Markets
Medtronic will soon take its first steps into both the dental market and the pediatric glucose monitor market
Medtronic InFuse Bone Graft Is “Approvable” For Oral Use – FDA Dental Panel
A possible reduction in morbidity associated with use of Medtronic's InFuse bone graft compared with conventional autograft treatment for oromaxillofacial bone defects outweighs potentially reduced efficacy of up to 20% and justifies FDA approval, the agency's Dental Products Panel agreed Nov. 9